SLC13A2, solute carrier family 13 member 2, 9058

N. diseases: 19; N. variants: 0
Disease: Nephrolithiasis ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0392525
Disease: Nephrolithiasis
Nephrolithiasis 		0.020 AlteredExpression disease BEFREE The results obtained from the renal expression of NaDC1 could explain an adaptive mechanism to prevent the formation of kidney stones by increasing the levels of citrate, a calcium chelator. 30140954 2018
CUI: C0392525
Disease: Nephrolithiasis
Nephrolithiasis 		0.020 Biomarker disease BEFREE We have thus identified for the first time a regulatory partner for NaDC1, and have gained novel mechanistic insight into the effect of CsA on renal citrate transport and kidney stone disease, as well as into the regulation of membrane transporters in general. 21257749 2011